Advertisement

Topics

Search Results for "Cancer Diagnostics"

15:06 EDT 29th March 2017 | BioPortfolio

Matching Channels

Matching News

Cancer Diagnostics: US, Europe, JapanCountry Segment Volume and Sales Forecasts, Laboratory Universe Prices from USD $2850

This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of lab...

20162021 Global Cancer Diagnostics Market Overview: Test Volume and Sales Forecasts by Country, Laboratory Universe Prices from USD $450

This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of lab...

Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer 20162020 Prices from USD $800

Scope of the ReportThe report entitled Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer 20162020, provides analysis of the global cancer diagnostics market and the US cancer diagno...

The Future of Cancer Diagnostics

Liquid biopsies move towards becoming the preferred method of monitoring tumors It’s no secret that cancer diagnostics play a central role in the realm of medical laboratory science. There’s a con...

ClearLight Diagnostics closes $2.6mm Series A round

ClearLight Diagnostics LLC raised $2.6mm through its Series A round from five investors. The company, which was formed last year under the name Clarity Solutions, is developing tissue processing and 3...

Exosome Diagnostics presents highest sensitivity liquid biopsy test for lung cancer

Exosome Diagnostics has presented data that sets a new standard for EGFR-T790M resistance mutation detection in lung cancer, with the highest sensitivity reported to date.

Cancer diagnostics company 20/20 GeneSystems brings in $4.5mm Series A round

Molecular diagnostics company 20/20 GeneSystems Inc. (protein analysis biomarkers for cancer) brought in $4.5mm though a Series A round from investors that included Ping An Ventures.

New method to diagnose cancer

An international group of scientists has created a new approach to the diagnostics of breast cancer with the help of nanoparticles of porous silicone.

Matching PubMed Articles

Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.

The importance of RAS mutation in carcinogenesis is established, and knowledge of an individual cancer's mutation status is important for optimal treatment.

Conformational SERS Classification of K-Ras Point Mutations for Cancer Diagnostics.

Point mutations in Ras oncogenes are routinely screened for diagnostics and treatment of tumors (especially in colorectal cancer). Here, we develop an optical approach based on direct SERS coupled wit...

Modern molecular biomarkers of head and neck cancer. Part I. Epigenetic diagnostics and prognostics: Systematic review.

Nearly half of the head and neck cancer cases are diagnosed in late stages. Traditional screening modalities have many disadvantages. The aim of the present article was to review the scientific litera...

MicroRNAs: A Puzzling Tool in Cancer Diagnostics and Therapy.

MicroRNAs (miRNAs) constitute a dominating class of small RNAs that regulate diverse cellular functions. Due the pivotal role of miRNAs in biological processes, a deregulated miRNA expression is likel...

Next-Generation Sequencing in Cancer Diagnostics.

This commentary highlights the article by Misyura et al that underscores the use of next-generation sequencing platforms for detection and verification of somatic variants.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement